Image

Early Outcomes and Nutritional Scores in Bariatric Patients

Early Outcomes and Nutritional Scores in Bariatric Patients

Recruiting
18-65 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This prospective observational study aims to evaluate whether preoperative immune-nutritional markers-specifically the Prognostic Nutritional Index (PNI), HALP score, Neutrophil-to-Lymphocyte Ratio (NLR), and C-Reactive Protein (CRP)-can predict early postoperative clinical outcomes such as time to oral intake, mobilization, complications, and length of hospital stay in patients undergoing elective laparoscopic sleeve gastrectomy.

Eligibility

Inclusion Criteria:

  • Age between 18 and 65 years
  • Body mass index (BMI) ≥ 35 kg/m²
  • Scheduled for elective laparoscopic sleeve gastrectomy
  • Availability of complete preoperative laboratory test results
  • Signed informed consent

Exclusion Criteria:

  • Severe hepatic or renal dysfunction
  • Presence of active infection
  • History of immunosuppressive therapy or hematologic malignancy
  • Need for intensive care unit (ICU) admission within the first 72 hours postoperatively
  • Preoperative administration of albumin or blood products

Study details
    Postoperative Complications
    Preoperative Nutritional Markers

NCT07007494

Istinye University

14 October 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.